Zenith new VP

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

masila

Rank: Vice President [?]

Points: 818 [?]

Votes: 16 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Zenith new VP

in response to

Re: Zenith new VP

BearDownAZ

posted on Dec 07, 2017 03:04PM

Haven't heard too much from Edward van der Horst since he was brought on in July. Is he helping to promote ZEL to a potential suitor who may be interested in ZEN 3694 or is he strictly on the science side of things? It would be nice to hear some progress on this front. I hope they haven't given up.